Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer

NCT00078572 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

408

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: capecitabine
DRUG: lapatinib (GW572016)

Sponsor

GlaxoSmithKline